• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

失代偿期肝硬化患者血浆精氨酸加压素与肾脏水代谢的关系

Relationship between plasma arginine vasopressin and renal water handling in decompensated cirrhosis.

作者信息

Epstein M, Weitzman R E, Preston S, DeNunzio A G

出版信息

Miner Electrolyte Metab. 1984;10(3):155-65.

PMID:6374413
Abstract

Although an impairment in renal water excretion is a commonly encountered clinical problem in cirrhotic patients, the mechanisms responsible for this abnormality are uncertain. ADH levels are elevated in some patients with decompensated cirrhosis, but a causal relationship between these levels and impaired water excretion has not been established. Since in normal man, water immersion to the neck (NI) results in a preferential central hypervolemia (CV), without plasma compositional change, and a resultant suppression of AVP, we designed the present study to determine if the diuretic response of cirrhotic patients to NI is mediated by a decrease in AVP. 17 cirrhotic patients with ascites were studied following 14 h of dehydration on two occasions: during a seated control study (C) and during 4 h of NI. AVP, determined by RIA, was measured every 30 min. 12 of the 17 patients manifested a diuresis that equalled or exceeded that documented in normal hydropenic subjects during immersion. NI did not alter mean AVP as compared with either the pre-study hour or those of the corresponding control study. Furthermore, peak V and CH2O varied independently of prestudy AVP (r = -0.116), mean change in AVP (r = -0.060), as well as nadir AVP levels (r = -0.122). The demonstration of a diuresis in some of the subjects, occurring without concomitant suppression of plasma AVP, suggests that ADH may constitute a permissive rather than pivotal factor in the impaired water excretion of many patients with advanced liver disease.

摘要

尽管肾排水功能受损是肝硬化患者常见的临床问题,但导致这种异常的机制尚不清楚。在一些失代偿期肝硬化患者中,抗利尿激素(ADH)水平升高,但这些水平与排水功能受损之间的因果关系尚未确立。由于在正常人中,颈部浸入水中(NI)会导致优先的中心血容量过多(CV),而血浆成分无变化,并导致抗利尿激素(AVP)分泌受抑制,我们设计了本研究以确定肝硬化患者对NI的利尿反应是否由AVP降低介导。17例有腹水的肝硬化患者在两次脱水14小时后进行研究:一次是坐位对照研究(C),另一次是4小时的NI研究。通过放射免疫分析(RIA)测定AVP,每30分钟测量一次。17例患者中有12例表现出的利尿作用等于或超过正常禁水受试者在浸入水中时记录的利尿作用。与研究前一小时或相应对照研究相比,NI并未改变平均AVP。此外,峰值V和水清除率(CH2O)的变化与研究前AVP(r = -0.116)、AVP的平均变化(r = -0.060)以及AVP最低水平(r = -0.122)无关。一些受试者出现利尿作用而血浆AVP未同时受抑制,这表明在许多晚期肝病患者的排水功能受损中,ADH可能是一个允许性而非关键因素。

相似文献

1
Relationship between plasma arginine vasopressin and renal water handling in decompensated cirrhosis.失代偿期肝硬化患者血浆精氨酸加压素与肾脏水代谢的关系
Miner Electrolyte Metab. 1984;10(3):155-65.
2
Effects of water immersion on plasma catecholamines in decompensated cirrhosis. Implications for deranged sodium and water homeostasis.
Miner Electrolyte Metab. 1985;11(1):25-34.
3
Isoosmotic central blood volume expansion suppresses plasma arginine vasopressin in normal man.等渗性中心血容量扩张抑制正常人血浆精氨酸加压素。
J Clin Endocrinol Metab. 1981 Feb;52(2):256-62. doi: 10.1210/jcem-52-2-256.
4
Refractory ascites in cirrhosis: roles of volume expansion and plasma atrial natriuretic factor level elevation.肝硬化难治性腹水:容量扩张和血浆心钠素水平升高的作用
Hepatology. 1993 Sep;18(3):519-28.
5
Determinants of deranged sodium and water homeostasis in decompensated cirrhosis.失代偿期肝硬化患者钠和水平衡紊乱的决定因素
J Lab Clin Med. 1976 May;87(5):822-39.
6
Alterations of vasoconstrictor and sodium-regulating hormone systems in vascularly decompensated liver cirrhosis.血管失代偿期肝硬化中血管收缩和钠调节激素系统的改变
Acta Med Hung. 1988;45(1):73-81.
7
Partial renal resistance to arginine vasopressin as an adaptation to high altitude living.肾脏对精氨酸加压素的部分抵抗作为对高原生活的一种适应。
Aviat Space Environ Med. 1998 Jan;69(1):58-65.
8
Failure of water immersion to influence parathyroid hormone secretion and renal phosphate handling in normal man.
J Lab Clin Med. 1976 Feb;87(2):218-26.
9
Therapeutic and diagnostic potential of a vasopressin-2 antagonist for impaired water handling in cirrhosis.血管加压素-2拮抗剂对肝硬化患者水代谢障碍的治疗及诊断潜力
Clin Pharmacol Ther. 1998 May;63(5):561-70. doi: 10.1016/S0009-9236(98)90107-2.
10
Hormonal regulation of water metabolism in children with nephrotic syndrome.肾病综合征患儿水代谢的激素调节
Kidney Int Suppl. 1987 Aug;21:S83-9.

引用本文的文献

1
Role of the cytochrome P-450/ epoxyeicosatrienoic acids pathway in the pathogenesis of renal dysfunction in cirrhosis.细胞色素 P-450/环氧二十碳三烯酸途径在肝硬化肾功能障碍发病机制中的作用。
Nephrol Dial Transplant. 2018 Aug 1;33(8):1333-1343. doi: 10.1093/ndt/gfx354.
2
Do vasopressin V2 receptor antagonists benefit cirrhotics with refractory ascites?血管加压素V2受体拮抗剂对顽固性腹水的肝硬化患者有益吗?
World J Gastroenterol. 2015 Nov 7;21(41):11584-96. doi: 10.3748/wjg.v21.i41.11584.
3
The Relationship between Renal Dysfunction and Abnormalities of the Immune System in Patients with Decompensated Cirrhosis.
失代偿期肝硬化患者肾功能不全与免疫系统异常的关系
ISRN Gastroenterol. 2012;2012:123826. doi: 10.5402/2012/123826. Epub 2012 Dec 26.
4
Pathogenetic background for treatment of ascites and hepatorenal syndrome.腹水和肝肾综合征治疗的发病机制背景。
Hepatol Int. 2008 Dec;2(4):416-28. doi: 10.1007/s12072-008-9100-3. Epub 2008 Sep 20.
5
The hepatorenal syndrome.肝肾综合征
Gut. 2001 Nov;49(5):729-37. doi: 10.1136/gut.49.5.729.
6
Sodium handling in patients with well compensated cirrhosis is dependent on the severity of liver disease and portal pressure.肝硬化代偿良好患者的钠代谢取决于肝脏疾病的严重程度和门静脉压力。
Gut. 2000 Apr;46(4):527-33. doi: 10.1136/gut.46.4.527.
7
The hepatorenal syndrome.肝肾综合征
Pediatr Nephrol. 1996 Feb;10(1):100-7. doi: 10.1007/BF00863460.
8
Enhancement of renal function with ornipressin in a patient with decompensated cirrhosis.去甲加压素对一名失代偿期肝硬化患者肾功能的改善作用
Gut. 1985 Dec;26(12):1385-6. doi: 10.1136/gut.26.12.1385.
9
Effect of captopril on renin and blood pressure in cirrhosis.
Eur J Clin Pharmacol. 1987;33(3):249-54. doi: 10.1007/BF00637557.